Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 4/21/2016 |
| Start Date: | January 2016 |
| End Date: | February 2016 |
The purpose of this study is to assess the effects of K-877 on the pharmacodynamics and the
pharmacokinetics of warfarin in healthy adults volunteers.
pharmacokinetics of warfarin in healthy adults volunteers.
Inclusion Criteria:
- Subject provides written informed consent before any study specific evaluation is
performed.
- Subject is a healthy adult male or female volunteer between the ages of 18 and 45
years, inclusive.
- Subject has a body mass index of 18 to 30 kg/m², inclusive.
Exclusion Criteria:
- Subject has clinically relevant abnormalities in the screening or check in
assessments.
- Subject has clinically significant out-of-range PT, INR, activated partial
thromboplastin time, fibrinogen, protein C, or protein S.
- Subject has abnormal prolongation of skin bleeding time at Screening.
We found this trial at
1
site
Click here to add this to my saved trials
